Toxicity of hypofractionated radiotherapy and TMZ in elderly patients with glioblastoma

被引：0
|
作者：
Payano, S. [1 ]
Zapatero, J. [1 ]
de las Penas, D. [1 ]
Amaya, E. [1 ]
Samper, P. [1 ]
机构：
[1] Hosp Univ Rey Juan Carlos, Radiat Oncol, Madrid, Spain
来源：
RADIOTHERAPY AND ONCOLOGY | 2022年 / 170卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-1153
引用
收藏
页码：S978 / S979
页数：2
相关论文
共 50 条
  • [31] RADIOTHERAPY IN THE TREATMENT OF ELDERLY GLIOBLASTOMA PATIENTS
    Hurmuz, Pervin
    Ozyigit, Gokhan
    Cengiz, Mustafa
    Yuce, Deniz
    Gultekin, Melis
    Yazici, Gozde
    Eren, Gulnihan
    Gurkaynak, Murat
    Zorlu, Faruk
    TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI, 2014, 17 (02): : 134 - 137
  • [32] A Phase 2 Trial of Neoadjuvant Temozolomide (TMZ) Followed By Accelerated Hypofractionated Radiation Therapy (AHRT) and TMZ Followed By Adjuvant TMZ in Patients with Newly Diagnosed Glioblastoma (GBM): Long Term Survival and Toxicity Analysis
    Shenouda, G.
    Souhami, L.
    Petrecca, K.
    Owen, S.
    Panet-Raymond, V.
    Carvalho, T.
    Guiot, M. C.
    Abdulkarim, B. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S48 - S49
  • [33] Management of patients with recurrent glioblastoma using hypofractionated stereotactic radiotherapy
    Dincoglan, Ferrat
    Beyzadeoglu, Murat
    Sager, Omer
    Demiral, Selcuk
    Gamsiz, Hakan
    Uysal, Bora
    Ebruli, Cuneyt
    Akin, Mustafa
    Oysul, Kaan
    Sirin, Sait
    Dirican, Bahar
    TUMORI JOURNAL, 2015, 101 (02): : 179 - 184
  • [34] Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: Efficacy and imaging analyses of the ARTE trial.
    Wirsching, Hans-Georg
    Tabatabai, Ghazaleh
    Roelcke, Ulrich
    Hottinger, Andreas Felix
    Schmid, Andrea
    Plasswilm, Ludwig
    Conen, Katrin Lisa
    Hundsberger, Thomas
    Caparrotti, Francesca
    Von Moos, Roger
    Riklin, Christian Alexander
    Remonda, Luca
    Roth, Patrick
    Held, Leonhard
    Rushing, Elisabeth Jane
    Ochsenbein, Adrian
    Weller, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [35] Hypofractionated adjuvant Radiotherapy in elderly Patients with Breast cancer
    Piefel, K.
    Schneider, T.
    Soeger, S.
    Glessmer, S.
    Bislich, O.
    Seegenschmiedt, M. H.
    Fehlauer, F.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2013, 189 : 81 - 81
  • [36] Tolerability of radical lung hypofractionated radiotherapy in elderly patients
    Otero Romero, A. M.
    Navarro-Domenech, I.
    Fernandez-Forne, A.
    Roman-Jobacho, A.
    Correa-Generoso, R.
    Garcia-Anaya, M.
    Garcia Rios, I.
    Ordonez-Marmolejo, R.
    Gomez-Millan, J.
    Perez-Rozos, A.
    Medina-Carmona, J.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S751 - S752
  • [37] Stereotactic Radiosurgery and Hypofractionated Radiotherapy for Glioblastoma
    Shah, Jennifer L.
    Li, Gordon
    Shaffer, Jenny L.
    Azoulay, Melissa I.
    Gibbs, Iris C.
    Nagpal, Seema
    Soltys, Scott G.
    NEUROSURGERY, 2018, 82 (01) : 24 - 34
  • [38] hypofractionated and intesified radiotherapy in glioblastoma multiforme
    Regueira, I. Nieto
    Ochagavia Galilea, V.
    Munoz Garzon, V.
    Naranjo, A.
    Sosa Fajardo, P.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S961 - S961
  • [39] Toxicity and Outcome of Radiotherapy with Concomitant and Adjuvant Temozolomide in Elderly Patients with Glioblastoma: A Retrospective Study
    Saito, Kuniaki
    Mukasa, Akitake
    Narita, Yoshitaka
    Tabei, Yusuke
    Shinoura, Nobusada
    Shibui, Soichiro
    Saito, Nobuhito
    NEUROLOGIA MEDICO-CHIRURGICA, 2014, 54 (04) : 272 - 279
  • [40] Phase II study of bevacizumab (BEV), temozolomide (TMZ), and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma (GBM).
    Omuro, A. A.
    Beal, K.
    Karimi, S.
    Chan, T. A.
    Panageas, K.
    Nayak, L.
    Seko, B.
    DeAngelis, L. M.
    Abrey, L. E.
    Gutin, P. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345